Shitara, K., Yamaguchi, K., Shoji, H., Lee, J., Ryu, M., Aghmesheh, M., Teran-Brage, E., Janjigian, Y. Y., Elimova, E., Holden, T., Szekeres, P., Yu, K., Thress, K., Barker, L., Origuchi, M., Galletti, G., Martinez, J., Raufi, A. G. (2026). Sonesitatug vedotin (Sone-Ve) monotherapy in patients (pts) with claudin 18.2–positive (CLDN18.2+) advanced or metastatic gastric or gastroesophageal junction (GEJ) cancers: Data from CLARITY-PanTumor01.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4023